Fair enough MM. The COO has corrected me a few times when I have pushed similar information, that SAS is NOT necessary, because of a grandfather agreement on stem-cell manufacturing licencing that takes precedent. Maybe its since changed? Who knows, but be it via the SAS or not, Physicians in Australia CAN prescribe ATI. Not many will without good RCT data. That is what we are getting shortly....he said, not daring to hold his breath.
Ann: Ortho-ATI Shoulder Tendon Study Database Lock, page-157
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
68.5¢ |
Change
0.030(4.58%) |
Mkt cap ! $162.5M | |||
| Open | High | Low | Value | Volume |
| 67.5¢ | 69.5¢ | 67.0¢ | $539.8K | 794.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1393 | 68.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.5¢ | 15395 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |